Hormone therapy was associated with a 19% lower relative risk in Black women aged 65 to 74 years. Among patients with T2DM, the risk of dementia and Alzheimer disease is lower in those treated with metformin. A 5-minute assessment was found to improve the diagnosis of mild cognitive impairment and dementia. People who inherit a history of Alzheimer disease from their mother's side have a higher risk of developing AD. Midpoint of sleep is associated with multiple measures of sleep quality and could be a biomarker for AD risk. Xanomeline-trospium chloride is effective and well tolerated in patients with schizophrenia experiencing acute psychosis. Individuals who suffer a stroke have a significantly increased risk of developing dementia. Former professional American football players who have medical and mental health conditions are at higher risk of CTE. A novel blood test could be used to effectively screen for Alzheimer disease, even before the onset of symptoms. Rafael Carbunaru talks about a recently approved software that benefits patients with Parkinson disease or essential tremor. Treatment with brexpiprazole led to a significant improvement in agitation for patients with dementia due to AD. Patients with type 1 diabetes who exhibit the presence of albuminuria have an escalated pace of brain atrophy. Duke Han, PhD, and Laura Fenton, a doctoral student, describe a study that shows the impact of cognitive impairment. Findings from a recent study suggest that racial disparities exist in the presentation of frontotemporal dementia. Individuals who are exposed to higher levels of air pollution over a long-term duration have a greater risk of dementia. Playing American football is linked with a higher risk of developing Parkinson disease. Individuals with depression have a significantly increased risk of developing dementia. The FDA converted the novel drug Leqembi, the first therapy proven to slow the course of Alzheimer disease, to full approval. The use of cholinesterase inhibitors improves psychotic symptoms in individuals with Alzheimer disease and Parkinson disease. Find out if the MIND diet is effective or not at reducing dementia in older adults.